Novavax (NVAX) Net Margin Growth (1y) (2011 - 2026)
Novavax (NVAX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | -8,460.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,460.00 |
| Dec 31, 2025 | 10,367.00 |
| Sep 30, 2025 | -14,376.00 |
| Jun 30, 2025 | 2,178.00 |
| Mar 31, 2025 | 23,501.00 |
| Dec 31, 2024 | -3,053.00 |
| Sep 30, 2024 | -7,359.00 |
| Jun 30, 2024 | 2,541.00 |
| Mar 31, 2024 | 20,585.00 |
| Dec 31, 2023 | -1,024.00 |
| Sep 30, 2023 | -4,699.00 |
| Jun 30, 2023 | 28,823.00 |
| Mar 31, 2023 | -39,196.00 |
| Dec 31, 2022 | 32,987.00 |
| Sep 30, 2022 | 15,733.00 |
| Jun 30, 2022 | -15,634.00 |
| Mar 31, 2022 | 7,869.00 |
| Dec 31, 2021 | -31,737.00 |
| Sep 30, 2021 | -5,463.00 |
| Jun 30, 2021 | -6,892.00 |